Old Web
English
Sign In
Acemap
>
authorDetail
>
Daniel Brust
Daniel Brust
Medicine
Medical research
Stable Disease
Pathology
Response rate (survey)
2
Papers
75
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (Removab) (anti-EpCAM x Anti-CD3): results of a phase 1/2 study.
2009
Journal of Immunotherapy
Martin Sebastian
Philipp Kiewe
Wolfgang Schuette
Daniel Brust
Christian Peschel
Folker Schneller
K. H. Rühle
Georg Nilius
Ralf Ewert
S. Lodziewski
Bernward Passlick
Wulf Sienel
Rainer Wiewrodt
Michael Jäger
Horst Lindhofer
H. Friccius Quecke
Alexander Schmittel
Show All
Source
Cite
Save
Citations (59)
Clinical Benefit in NSCLC: Advanced-Stage Patients Require Symptom-Improving Palliation. Experiences from the ‘Iressa’ Expanded Access Program
2005
Onkologie
Wolfgang Schuette
Sylke Nagel
Steffen Schaedlich
Daniel Brust
Thomas Blankenburg
Show All
Source
Cite
Save
Citations (16)
1